Toyosi Onwuemene/LinkedIn
Jun 11, 2026, 16:25
Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
Toyosi Onwuemene, Associate Professor with tenure Duke University School of Medicine, shared a post on LinkedIn:
”A patient developed a pulmonary embolism.
He was started on anticoagulation.
Two days later, he developed gastrointestinal bleeding.
Anticoagulation was stopped.
Multiple specialists became involved.
One question remained:
When should anticoagulation be restarted?
It seemed like a straightforward question.
Yet, no one owned the decision.
In the latest edition of Hematology Access Insights, I explore what clinician interviews revealed about expertise, access, and decision-making in bleeding and clotting care.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 16:46Moaz Abouelmagd: Key Findings from a Large Network Meta-Analysis of IV Thrombolytics in Acute Ischemic Stroke
-
Jun 11, 2026, 16:37Wolfgang Miesbach: From Failed Intravitreal Trials to Real Benefit – Subretinal AAV8 Gene Therapy in Pediatric X-Linked Retinoschisis
-
Jun 11, 2026, 16:34Joao Mariano Pego: Advancing Coagulation Diagnostics Through Standardized Thrombin Generation
-
Jun 11, 2026, 16:33Ifeanyichukwu Ifechidere: Nobody Talks About Thrombosis in Sickle Cell Disease
-
Jun 11, 2026, 16:31Karim Mahawish: Ischaemic Stroke Despite Anticoagulation in Atrial Fibrillation
-
Jun 11, 2026, 16:29Salim Virani: The 2026 ACC/AHA Multisociety Dyslipidemia Guideline Promotes Early Prevention
-
Jun 11, 2026, 16:20Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
-
Jun 11, 2026, 16:19Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
-
Jun 11, 2026, 15:50Shatri Albertina: New Publication on DVT Among Surgical Patients Receiving Thromboprophylaxis